ANDA 216172

MANKIND PHARMA

FDA Drug Application

Application #216172

Application Sponsors

ANDA 216172

MANKIND PHARMA

Marketing Status

• Prescription: 001
• Prescription: 002
• Prescription: 003
• Prescription: 004

Application Products

001	TABLET;ORAL	EQ 2.5MG BASE	0	NEBIVOLOL HYDROCHLORIDE	NEBIVOLOL HYDROCHLORIDE
002	TABLET;ORAL	EQ 5MG BASE	0	NEBIVOLOL HYDROCHLORIDE	NEBIVOLOL HYDROCHLORIDE
003	TABLET;ORAL	EQ 10MG BASE	0	NEBIVOLOL HYDROCHLORIDE	NEBIVOLOL HYDROCHLORIDE
004	TABLET;ORAL	EQ 20MG BASE	0	NEBIVOLOL HYDROCHLORIDE	NEBIVOLOL HYDROCHLORIDE

FDA Submissions

UNKNOWN;

ORIG

1

AP

2022-11-14

STANDARD

Submissions Property Types

ORIG

1

Null

7

TE Codes

001	Prescription	AB
002	Prescription	AB
003	Prescription	AB
004	Prescription	AB

CDER Filings

MANKIND PHARMA

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216172
            [companyName] => MANKIND PHARMA
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEBIVOLOL HYDROCHLORIDE","activeIngredients":"NEBIVOLOL HYDROCHLORIDE","strength":"EQ 2.5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NEBIVOLOL HYDROCHLORIDE","activeIngredients":"NEBIVOLOL HYDROCHLORIDE","strength":"EQ 5MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NEBIVOLOL HYDROCHLORIDE","activeIngredients":"NEBIVOLOL HYDROCHLORIDE","strength":"EQ 10MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"NEBIVOLOL HYDROCHLORIDE","activeIngredients":"NEBIVOLOL HYDROCHLORIDE","strength":"EQ 20MG BASE","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/14\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2022-11-14
        )

)